Peregrine Pharmaceuticals, Inc. - Investor Relations

Investor Relations

Peregrine Pharmaceuticals, Inc.	Corporate and Media Relations	Investors
14282 Franklin Avenue, Tustin, CA 92780 Phone: 714-508-6000 Fax: 714-838-5817	Linda Donaldson 14282 Franklin Avenue Tustin, CA 92780 Tel: 714-508-6067 Fax: 714-838-5817 pr@peregrineinc.com	GendeLLindheim BioCom Partners, LLC Barbara Lindheim 48 Wall Street, Suite 1100 New York, NY 10005 Tel: 212-918-4949 Tel: 800-987-8256

Featured Event

Mar 11, 2010
Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter Fiscal Year 2010

Mar 5, 2010
Peregrine Pharmaceuticals to Report Third Quarter FY 2010 Financial Results

Mar 11, 2010 at 11:30 AM ET
Third Quarter Fiscal Year 2010 Financial Results

Mar 17, 2010 at 12:30 PM PT
ROTH 22nd Annual OC Growth Stock Conference

NASDAQ:PPHM
$3.42 - 0.11

Mar 11, 2010
3:58 PM ET

Quotes delayed at least 20 minutes. Information provided by eSignal.

Shareholder Tools